[In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
Klinik für Urologie, Medizinische Fakultät, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden. Doreen.kunze@uniklinikum-dresden.de
D
D
Kunze
S
S
Füssel
A
A
Meye
D
D
Wuttig
K
K
Krämer
M
M
Kotzsch
M
M
Toma
B
B
Schwenzer
I
I
Kausch
D
D
Jocham
O W
OW
Hakenberg
M O
MO
Grimm
M P
MP
Wirth
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009368:Neoplasm Transplantation; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use*; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000187:drug effects*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology
D014408:Biomarkers, Tumor; D020319:Oligodeoxyribonucleotides, Antisense; D034741:RNA, Small Interfering